Press Releases

Title Filter

Display #

#	Article Title
1	October 4, 2011 - Mymetics reclaims innovative intra-nasal influenza vaccine
2	May 26, 2011 - Completion of Successful Phase I Study
3	March 7, 2011 - Copy of 8 K file with SEC regarding OTC listing
4	February 15, 2011 - Publication in scientific journal Immunity
5	November 29, 2010 - Mymetics Secures New Patent for Virosome based Vaccines
6	November 30, 2010 - Mymetics HIV Vaccine Shows Strong Preliminary Phase I Data
7	September 13, 2010 - Mymetics’ novel HIV vaccine to begin new NIH-funded study at University of California, Davis
8	August 11, 2010 - Mymetics Corporation announces new Chief Financial Officer
9	June 28, 2010 - Mymetics’ Respiratory Syncytial Virus (RSV) vaccine protects from viral challenge in pre-clinical study
10	June 16, 2010 - Mymetics’ Phase Ib Malaria Vaccine: Safe, Well Tolerated and Long-Lasting Antibody Response in Children in Tanzania

Page 1 of 3

Start

Prev

1

2

3

Next

End

Standard&Poors - Analysis Report

To see the latest S&P report on Mymetics, click here:

© COPYRIGHT Mymetics 2009